Simplifying Global Compliance
Articles Tagged with ''Daily International Pharma Alert''
South Africa's Department of Health has announced its new multimillion-dollar plan to combat HIV, which includes significant funding for HIV treatment, through 2011. Read More
The U.S. Centers for Disease Control and Prevention (CDC) has released new safety data on Merck's RotaTeq rotavirus vaccine showing that the vaccine does not pose an elevated risk for intussusception, the most common cause of bowel obstruction in infants. Read More
To help companies move to electronic common technical document (eCTD) format, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) announced it will accept electronic submissions that are compliant with the folder structure and naming conventions of the eCTD standard but that do not have an extensible markup language (XML) backbone. Read More
Bristol-Myers Squibb (BMS) is expanding its R&D capabilities in India through separate partnerships with Biocon and Accenture. Read More
Xechem International announced that its subsidiary Xechem Pharmaceuticals Nigeria expects to soon be able to scale up production of its drug for sickle cell disease with the arrival of new equipment. Read More
The FDA has requested that all manufacturers of sedative-hypnotic drug products strengthen their product labeling to include stronger language about potential risks. Read More
The European Medicines Agency (EMEA) has announced that it reviewed more new drugs in 2006 than in any previous year. Read More
The Chinese Ministry of Health has announced a new rule mandating that doctors use the generic names of drugs when writing prescriptions, the country's government news agency Xinhua has reported. Read More
A Nigerian high court has ruled in favor of Pfizer in a patent infringement suit brought against two local companies, Tyonex Nigeria and Ebamic Pharmacy, for selling an unauthorized drug containing the same active ingredient as Pfizer's hypertension drug Norvasc, reports the Lagos, Nigeria-based daily newspaper Vanguard. Read More
GlaxoSmithKline's (GSK) kinase inhibitor Tykerb has gained FDA approval for use in combination with Roche's oral chemotherapeutic Xeloda for the treatment of advanced metastatic breast cancer specifically in tumors that produce an excess of the HER2 protein. Read More
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing